Skip to main content

Animations

MJFF Publications

4711 - 4720 of 8620 Results
Title
Year
  • Year
  • 2021
  • 2023
  • 2016
  • 2018
  • 2025
  • 2023
  • 2021
  • 2019
  • 2018
  • 2025
  • Summary Details
    OPEN
    Title: Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.006
    Citation Count: 22
  • Summary Details
    RESTRICTED
    Title: Development of a highly potent and selective degrader of LRRK2
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2023.129449
    Citation Count: 13
  • Summary Details
    RESTRICTED
    Title: Effect of tricyclic antidepressants on L-DOPA-induced dyskinesia and motor improvement in hemi-parkinsonian rats
    Journal Name: Pharmacology Biochemistry and Behavior
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pbb.2016.01.004
    Best OA location URL:
    Citation Count: 22
  • Summary Details
    OPEN
    Title: USP 14 inhibition corrects an in vivo model of impaired mitophagy
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.201809014
    Citation Count: 93
  • Summary Details
    OPEN
    Title: Cognitive impairment and dementia in Latin American individuals with parkinsonism and Parkinson's disease: A 10/66 Dementia Research Group study
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.70371
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Population fraction of Parkinson’s disease attributable to preventable risk factors
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00603-z
    Citation Count: 10
  • Summary Details
    OPEN
    Title: ATG4 family proteins drive phagophore growth independently of the LC3/GABARAP lipidation system
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.molcel.2021.03.001
    Citation Count: 70
  • Summary Details
    OPEN
    Title: Cysteine oxidation and redox signaling in dopaminergic neurons physiology and in Parkinson’s disease
    Journal Name: Current Opinion in Physiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.cophys.2019.04.025
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Multiple system atrophy and apolipoprotein E
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27297
    Citation Count: 19
  • Summary Details
    RESTRICTED
    Title: Local Regulation of Striatal Dopamine Release Shifts from Predominantly Cholinergic in Mice to GABAergic in Macaques
    Journal Name: The Journal of Neuroscience
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1523/jneurosci.1692-24.2025
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.